OBJECTIVE: Technological advances in surgical management of endometrial cancer (EC) may allow for novel risk modification in surgical site infection (SSI). METHODS: Perioperative variables were abstracted from EC cases surgically staged between January 1, 1999, and December 31, 2008. Primary outcome was SSI, as defined by American College of Surgeons National Surgical Quality Improvement Program. Counseling and global models were built to assess perioperative predictors of superficial incisional SSI and organ/space SSI. Thirty-day cost of SSI was calculated. RESULTS: Among 1369 EC patients, 136 (9.9%) had SSI. In the counseling model, significant predictors of superficial incisional SSI were obesity, American Society of Anesthesiologists (ASA) score >2, preoperative anemia (hematocrit <36%), and laparotomy. In the global model, significant predictors of superficial incisional SSI were obesity, ASA score >2, smoking, laparotomy, and intraoperative transfusion. Counseling model predictors of organ/space SSI were older age, smoking, preoperative glucose >110 mg/dL, and prior methicillin-resistant Staphylococcus aureus (MRSA) infection. Global predictors of organ/space SSI were older age, smoking, vascular disease, prior MRSA infection, greater estimated blood loss, and lymphadenectomy or bowel resection. SSI resulted in a $5447 median increase in 30-day cost. CONCLUSIONS: Our findings are useful to individualize preoperative risk counseling. Hyperglycemia and smoking are modifiable, and minimally invasive surgical approaches should be the preferred surgical route because they decrease SSI events. Judicious use of lymphadenectomy may decrease SSI. Thirty-day postoperative costs are considerably increased when SSI occurs.
OBJECTIVE: Technological advances in surgical management of endometrial cancer (EC) may allow for novel risk modification in surgical site infection (SSI). METHODS: Perioperative variables were abstracted from EC cases surgically staged between January 1, 1999, and December 31, 2008. Primary outcome was SSI, as defined by American College of Surgeons National Surgical Quality Improvement Program. Counseling and global models were built to assess perioperative predictors of superficial incisional SSI and organ/space SSI. Thirty-day cost of SSI was calculated. RESULTS: Among 1369 EC patients, 136 (9.9%) had SSI. In the counseling model, significant predictors of superficial incisional SSI were obesity, American Society of Anesthesiologists (ASA) score >2, preoperative anemia (hematocrit <36%), and laparotomy. In the global model, significant predictors of superficial incisional SSI were obesity, ASA score >2, smoking, laparotomy, and intraoperative transfusion. Counseling model predictors of organ/space SSI were older age, smoking, preoperative glucose >110 mg/dL, and prior methicillin-resistant Staphylococcus aureus (MRSA) infection. Global predictors of organ/space SSI were older age, smoking, vascular disease, prior MRSA infection, greater estimated blood loss, and lymphadenectomy or bowel resection. SSI resulted in a $5447 median increase in 30-day cost. CONCLUSIONS: Our findings are useful to individualize preoperative risk counseling. Hyperglycemia and smoking are modifiable, and minimally invasive surgical approaches should be the preferred surgical route because they decrease SSI events. Judicious use of lymphadenectomy may decrease SSI. Thirty-day postoperative costs are considerably increased when SSI occurs.
Authors: Srinivas Kondalsamy-Chennakesavan; Monika Janda; Val Gebski; Jannah Baker; Alison Brand; Russell Hogg; Thomas W Jobling; Russell Land; Tom Manolitsas; Marcelo Nascimento; Deborah Neesham; James L Nicklin; Martin K Oehler; Geoff Otton; Lewis Perrin; Stuart Salfinger; Ian Hammond; Yee Leung; Peter Sykes; Hextan Ngan; Andrea Garrett; Michael Laney; Tong Yow Ng; Karfai Tam; Karen Chan; David H Wrede; Selvan Pather; Bryony Simcock; Rhonda Farrell; Gregory Robertson; Graeme Walker; Anthony McCartney; Andreas Obermair Journal: Eur J Cancer Date: 2012-04-12 Impact factor: 9.162
Authors: Jonathan R Edwards; Kelly D Peterson; Yi Mu; Shailendra Banerjee; Katherine Allen-Bridson; Gloria Morrell; Margaret A Dudeck; Daniel A Pollock; Teresa C Horan Journal: Am J Infect Control Date: 2009-12 Impact factor: 2.918
Authors: Bruce L Hall; Barton H Hamilton; Karen Richards; Karl Y Bilimoria; Mark E Cohen; Clifford Y Ko Journal: Ann Surg Date: 2009-09 Impact factor: 12.969
Authors: Christine M Friedenreich; Rita K Biel; David C W Lau; Ilona Csizmadi; Kerry S Courneya; Anthony M Magliocco; Yutaka Yasui; Linda S Cook Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-09-15 Impact factor: 4.254
Authors: Robert L Smith; Jamie K Bohl; Shannon T McElearney; Charles M Friel; Margaret M Barclay; Robert G Sawyer; Eugene F Foley Journal: Ann Surg Date: 2004-05 Impact factor: 12.969
Authors: Michelle Kuznicki; Adrianne Mallen; Emily Clair McClung; Sharon E Robertson; Sarah Todd; David Boulware; Stacy Martin; Rod Quilitz; Roberto J Vargas; Sachin M Apte Journal: Int J Gynecol Cancer Date: 2020-07-29 Impact factor: 3.437
Authors: Lauren S Prescott; Thomas A Aloia; Alaina J Brown; Jolyn S Taylor; Mark F Munsell; Charlotte C Sun; Kathleen M Schmeler; Charles F Levenback; Diane C Bodurka Journal: Gynecol Oncol Date: 2014-11-14 Impact factor: 5.482
Authors: Sumer K Wallace; Jessica W Halverson; Christopher J Jankowski; Stephanie R DeJong; Amy L Weaver; Megan R Weinhold; Bijan J Borah; James P Moriarty; William A Cliby; Daryl J Kor; Andrew A Higgins; Hilary A Otto; Sean C Dowdy; Jamie N Bakkum-Gamez Journal: Obstet Gynecol Date: 2018-05 Impact factor: 7.661
Authors: Mariam M AlHilli; Andrea Mariani; Jamie N Bakkum-Gamez; Sean C Dowdy; Amy L Weaver; Preema P Peethambaram; Gary L Keeney; William A Cliby; Karl C Podratz Journal: Gynecol Oncol Date: 2014-03-29 Impact factor: 5.482
Authors: Ricardo Sainz de la Cuesta; Rosa Mohedano; Sylvia Sainz de la Cuesta; Belen Guzman; Alicia Serrera; Silvia Paulos; Margarita Rubio Journal: PLoS One Date: 2021-01-12 Impact factor: 3.240